The Head New Product Innovation steers the strategic vision, design, and execution of next-generation dental implant systems, prosthetic components, and integrated digital solutions. Bridge clinical dental trends with technical reality while ensuring strict compliance with global MDR standards.
Leadership & Dental Innovation Pipeline
Lead the NPI Engineering team, fostering a culture of innovation, accountability, and continuous improvement.
Drive the long-term product innovation roadmap for dental implants, prosthetic portfolios, and digital ecosystem solutions (e.g., guided surgery, CAD/CAM workflows, software integration).
Lead the evaluation, benchmarking, and clinical testing of competitor dental systems to identify market gaps and technological opportunities.
Oversee the successful design transfer of complex implantology and digital development projects from initial concept to commercial production.
Establish, maintain, and enhance NPI KPIs such as robustness, manufacturability, maintainability, cost efficiency, sustainability, and reliability.
Communicate technical and strategic priorities to senior leadership and cross-functional stakeholders.
Project & Process Management
Direct and manage product development, ensuring mechanical integrity, biological compatibility, and milestone achievements.
Approve and finalize critical development documentation, establishing robust Design History Files (DHF) that comply with global medical device standards.
Supervise the creation and optimization of manufacturing drawings, device descriptions, packaging specifications, and precision assembly tolerance structures.
Support audits, technical reviews, and risk assessments related to product changes and updates.
Ensure all NPI engineering activities comply with internal standards, industry regulations, and documentation requirements.
Cross-Functional & Clinical Collaboration
Act as the primary technical partner for Brand Management, International Sales, Key Opinion Leaders (KOLs), and clinicians to transform clinical needs into high-performance product designs.
Guide production and testing teams during the implementation phase, ensuring component test layouts and 3D visualization materials meet commercial standards
Partner with Life Cycle Engineering, Operations, and Markets to ensure seamless transitions between product development stages.
Serve as the technical escalation point for product performance issues, field feedback, and customer complaints.
The tasks are to be performed in compliance with the company principles, the company objectives and the defined QM system. Representation in the event of absence is determined on a department-specific and individual basis.
Camlog is a leading provider of complete systems and products for dental implantology and restorative dentistry. Many years of research and development experience, high quality standards, fair value for money, and practice-oriented services have made Camlog one of the top names in the industry.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
